199 related articles for article (PubMed ID: 25240616)
21. Anticancer activities of novel chalcone and bis-chalcone derivatives.
Modzelewska A; Pettit C; Achanta G; Davidson NE; Huang P; Khan SR
Bioorg Med Chem; 2006 May; 14(10):3491-5. PubMed ID: 16434201
[TBL] [Abstract][Full Text] [Related]
22. Mild C(sp
Romo-Pérez A; Miranda LD; Chávez-Blanco AD; Dueñas-González A; Camacho-Corona MDR; Acosta-Huerta A; García A
Eur J Med Chem; 2017 Sep; 138():1-12. PubMed ID: 28641156
[TBL] [Abstract][Full Text] [Related]
23. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
24. 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells.
Kim SY; Lee IS; Moon A
Chem Biol Interact; 2013 May; 203(3):565-72. PubMed ID: 23562496
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, antitumor and antibacterial activities of some novel tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives.
Abbas SE; Abdel Gawad NM; George RF; Akar YA
Eur J Med Chem; 2013 Jul; 65():195-204. PubMed ID: 23708013
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
[TBL] [Abstract][Full Text] [Related]
27. 7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer.
Kandil S; Westwell AD; McGuigan C
Bioorg Med Chem Lett; 2016 Apr; 26(8):2000-4. PubMed ID: 26965862
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of 2-alkoxy and 2-benzyloxy analogues of estradiol as anti-breast cancer agents through microtubule stabilization.
Sathish Kumar B; Kumar A; Singh J; Hasanain M; Singh A; Fatima K; Yadav DK; Shukla V; Luqman S; Khan F; Chanda D; Sarkar J; Konwar R; Dwivedi A; Negi AS
Eur J Med Chem; 2014 Oct; 86():740-51. PubMed ID: 25238172
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
Rao GW; Xu GJ; Wang J; Jiang XL; Li HB
ChemMedChem; 2013 Jun; 8(6):928-33. PubMed ID: 23640754
[TBL] [Abstract][Full Text] [Related]
30. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity and gene expression profiles of novel synthesized steroid derivatives as chemotherapeutic anti-breast cancer agents.
Elmegeed GA; Khalil WK; Mohareb RM; Ahmed HH; Abd-Elhalim MM; Elsayed GH
Bioorg Med Chem; 2011 Nov; 19(22):6860-72. PubMed ID: 22000946
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents.
Lv Z; Zhang Y; Zhang M; Chen H; Sun Z; Geng D; Niu C; Li K
Eur J Med Chem; 2013 Sep; 67():447-53. PubMed ID: 23920246
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel benzo[4,5]thiazolo[1,2-a]pyrimidine-3-carboxylate derivatives and biological evaluation as potential anticancer agents.
Nagarapu L; Vanaparthi S; Bantu R; Ganesh Kumar C
Eur J Med Chem; 2013 Nov; 69():817-22. PubMed ID: 24113366
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
[TBL] [Abstract][Full Text] [Related]
36. Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: part I.
Caruso A; Chimento A; El-Kashef H; Lancelot JC; Panno A; Pezzi V; Saturnino C; Sinicropi MS; Sirianni R; Rault S
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):609-13. PubMed ID: 21883039
[TBL] [Abstract][Full Text] [Related]
37. Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
Siddiqui RA; Harvey KA; Xu Z; Natarajan SK; Davisson VJ
Bioorg Med Chem; 2014 Mar; 22(6):1899-908. PubMed ID: 24556504
[TBL] [Abstract][Full Text] [Related]
38. Novel R-(+)-limonene-based thiosemicarbazones and their antitumor activity against human tumor cell lines.
Vandresen F; Falzirolli H; Almeida Batista SA; da Silva-Giardini AP; de Oliveira DN; Catharino RR; Ruiz AL; de Carvalho JE; Foglio MA; da Silva CC
Eur J Med Chem; 2014 May; 79():110-6. PubMed ID: 24727464
[TBL] [Abstract][Full Text] [Related]
39. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and cytotoxicity of (+/-)-7,9-dideoxy-pancratistatin analogues.
Nieto-García O; Alonso R
Org Biomol Chem; 2013 Jan; 11(3):515-22. PubMed ID: 23207545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]